Rapport Therapeutics (RAPP) Stock
Rapport Therapeutics (RAPP) closed at $24.82 on Nov 16, 2026; its Tenet Score is 59 of 100 against 313 Healthcare peers.
31 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $24.82
- Nov 16, 2026
- Market cap
- $1.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 22.06 – 52.93
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 59/100
- Mixed · 313 Healthcare peers
Industry: Pharmaceutical Preparations
Rapport Therapeutics Inc. scores 59/100. Mixed. Strongest on financial health, quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 59 is built from 3 of 4 pillars, from 50% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=313Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Quality Floor
13F flows & insider trades land here.
We are a clinical-stage biopharmaceutical company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (“CNS”) disorders. Neuronal receptors are complex assemblies of proteins,…
Similar-sized companies in Pharmaceutical Preparations
The 5 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| MBX Biosciences Inc.MBX | 52 | $2.7B |
| Septerna Inc.SEPN | 54 | $2.0B |
| Zenas Biopharma Inc.ZBIO | 29 | $1.9B |
| Alto Neuroscience Inc.ANRO | 52 | $1.2B |
| Bicara Therapeutics Inc.BCAX | 61 | $685.1M |
Common questions
What sector and industry is Rapport Therapeutics in?
Rapport Therapeutics is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Rapport Therapeutics' Tenet Score?
Rapport Therapeutics' Tenet Score is 59 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




